115 related articles for article (PubMed ID: 3971363)
1. [3H]Methotrexate loss from the rat brain following enhanced uptake by osmotic opening of the blood-brain barrier.
Ohata M; Fredericks WR; Neuwelt EA; Sundaram U; Rapoport SI
Cancer Res; 1985 Mar; 45(3):1092-6. PubMed ID: 3971363
[TBL] [Abstract][Full Text] [Related]
2. Osmotic opening of the blood-brain barrier to methotrexate in the rat.
Ohno K; Fredericks WR; Rapoport SI
Surg Neurol; 1979 Oct; 12(4):323-8. PubMed ID: 524251
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study.
Shapiro WR; Voorhies RM; Hiesiger EM; Sher PB; Basler GA; Lipschutz LE
Cancer Res; 1988 Feb; 48(3):694-701. PubMed ID: 3335031
[TBL] [Abstract][Full Text] [Related]
4. Differential blood-brain barrier permeabilities to [14C]sucrose and [3H]inulin after osmotic opening in the rat.
Ziylan YZ; Robinson PJ; Rapoport SI
Exp Neurol; 1983 Mar; 79(3):845-57. PubMed ID: 6825767
[TBL] [Abstract][Full Text] [Related]
5. Blood-brain barrier permeability to sucrose and dextran after osmotic opening.
Ziylan YZ; Robinson PJ; Rapoport SI
Am J Physiol; 1984 Oct; 247(4 Pt 2):R634-8. PubMed ID: 6208789
[TBL] [Abstract][Full Text] [Related]
6. Intracarotid infusion of hypertonic mannitol changes permeability of blood-brain barrier to methotrexate in rats.
Pan GY; Liu XD; Liu GQ
Acta Pharmacol Sin; 2000 Jul; 21(7):613-6. PubMed ID: 11360668
[TBL] [Abstract][Full Text] [Related]
7. Quantitative assessment of blood-brain barrier damage during microdialysis.
Morgan ME; Singhal D; Anderson BD
J Pharmacol Exp Ther; 1996 May; 277(2):1167-76. PubMed ID: 8627529
[TBL] [Abstract][Full Text] [Related]
8. Distribution and degradation of [3H]methotrexate after intravenous and cerebral intraventricular injection in primates.
Kimelberg HK; Biddlecome SM; Bourke RS
Cancer Res; 1977 Jan; 37(1):157-65. PubMed ID: 401470
[TBL] [Abstract][Full Text] [Related]
9. Epinephrine increases the selective permeability of epidurally administered [3H]-D-mannitol and [14C]-carboxyl-inulin across the blood-spinal cord barrier.
Naidu KA; Fu ES; Prockop LD
J Spinal Cord Med; 1996 Jul; 19(3):176-82. PubMed ID: 8819025
[TBL] [Abstract][Full Text] [Related]
10. Defining the lower limits of blood-brain barrier permeability: factors affecting the magnitude and interpretation of permeability-area products.
Preston E; Haas N
J Neurosci Res; 1986; 16(4):709-19. PubMed ID: 3098986
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.
Zylber-Katz E; Gomori JM; Schwartz A; Lossos A; Bokstein F; Siegal T
Clin Pharmacol Ther; 2000 Jun; 67(6):631-41. PubMed ID: 10872645
[TBL] [Abstract][Full Text] [Related]
12. Decreased delivery and acute toxicity of cranial irradiation and chemotherapy given with osmotic blood-brain barrier disruption in a rodent model: the issue of sequence.
Remsen LG; McCormick CI; Sexton G; Pearse HD; Garcia R; Neuwelt EA
Clin Cancer Res; 1995 Jul; 1(7):731-9. PubMed ID: 9816039
[TBL] [Abstract][Full Text] [Related]
13. Time course of hyperosmolar opening of the blood-brain and blood-CSF barriers in spontaneously hypertensive rats.
Al-Sarraf H; Ghaaedi F; Redzic Z
J Vasc Res; 2007; 44(2):99-109. PubMed ID: 17191032
[TBL] [Abstract][Full Text] [Related]
14. Differential passage of [14C]sucrose and [3H]inulin across rat blood-brain barrier after cerebral ischemia.
Preston E; Webster J
Acta Neuropathol; 2002 Mar; 103(3):237-42. PubMed ID: 11907803
[TBL] [Abstract][Full Text] [Related]
15. Size-dependent blood-brain barrier opening demonstrated with [14C]sucrose and a 200,000-Da [3H]dextran.
Armstrong BK; Robinson PJ; Rapoport SI
Exp Neurol; 1987 Sep; 97(3):686-96. PubMed ID: 2442027
[TBL] [Abstract][Full Text] [Related]
16. Quantitative aspects of reversible osmotic opening of the blood-brain barrier.
Rapoport SI; Fredericks WR; Ohno K; Pettigrew KD
Am J Physiol; 1980 May; 238(5):R421-31. PubMed ID: 7377381
[TBL] [Abstract][Full Text] [Related]
17. Reduced permeation of 14C-sucrose, 3H-mannitol and 3H-inulin across blood-brain barrier in nephrectomized rats.
Preston E; Haas N; Allen M
Brain Res Bull; 1984 Jan; 12(1):133-6. PubMed ID: 6424869
[TBL] [Abstract][Full Text] [Related]
18. Structural specificity of mechanisms controlling the hepatic uptake and biliary output of methotrexate in the rat.
Deutsch JC; Kolhouse JF
J Pharmacol Exp Ther; 1989 Jul; 250(1):221-6. PubMed ID: 2746499
[TBL] [Abstract][Full Text] [Related]
19. Delivery of human interferon-alpha to brain by transient osmotic blood-brain barrier modification in the rat.
Greig NH; Fredericks WR; Holloway HW; Soncrant TT; Rapoport SI
J Pharmacol Exp Ther; 1988 May; 245(2):581-6. PubMed ID: 3367308
[TBL] [Abstract][Full Text] [Related]
20. Effects of single-dose and fractionated cranial irradiation on rat brain accumulation of methotrexate.
Kamen BA; Moulder JE; Kun LE; Ring BJ; Adams SM; Fish BL; Holcenberg JS
Cancer Res; 1984 Nov; 44(11):5092-4. PubMed ID: 6488169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
